The results further revealed reduced FGF9 and CCND2 staining intensities in xenograft tumors in the miR-4317 agomir group compared with the NC group, indicating a decrease in tumor cell proliferation in response to the downregulation of miR-4317. Here, CCND2 is linked to neoplasm.